Arcus Biosciences, Inc. (RCUS)
24.42
+0.59
(+2.48%)
USD |
NYSE |
Oct 09, 16:00
24.42
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Market Cap : 3.101B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 3.026B |
| October 07, 2026 | 3.114B |
| October 06, 2026 | 3.084B |
| October 05, 2026 | 3.142B |
| October 02, 2026 | 3.104B |
| October 01, 2026 | 3.204B |
| September 30, 2026 | 3.280B |
| September 29, 2026 | 3.258B |
| September 28, 2026 | 3.176B |
| September 25, 2026 | 3.171B |
| September 24, 2026 | 3.183B |
| September 23, 2026 | 3.352B |
| September 22, 2026 | 3.412B |
| September 21, 2026 | 3.296B |
| September 18, 2026 | 3.205B |
| September 17, 2026 | 3.244B |
| September 16, 2026 | 3.131B |
| September 15, 2026 | 3.089B |
| September 14, 2026 | 3.057B |
| September 11, 2026 | 3.123B |
| September 10, 2026 | 3.321B |
| September 09, 2026 | 3.618B |
| September 08, 2026 | 3.691B |
| September 04, 2026 | 3.767B |
| September 03, 2026 | 3.827B |
| Date | Value |
|---|---|
| September 02, 2026 | 3.791B |
| September 01, 2026 | 3.773B |
| August 31, 2026 | 3.719B |
| August 28, 2026 | 3.710B |
| August 27, 2026 | 3.885B |
| August 26, 2026 | 3.907B |
| August 25, 2026 | 4.009B |
| August 24, 2026 | 3.825B |
| August 21, 2026 | 3.853B |
| August 20, 2026 | 3.749B |
| August 19, 2026 | 3.854B |
| August 18, 2026 | 3.748B |
| August 17, 2026 | 3.754B |
| August 14, 2026 | 3.744B |
| August 13, 2026 | 3.665B |
| August 12, 2026 | 3.678B |
| August 11, 2026 | 3.650B |
| August 10, 2026 | 3.647B |
| August 07, 2026 | 3.635B |
| August 06, 2026 | 3.598B |
| August 05, 2026 | 3.518B |
| August 04, 2026 | 3.658B |
| August 03, 2026 | 3.508B |
| July 31, 2026 | 3.538B |
| July 30, 2026 | 3.545B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 12.60B |
| AVITA Medical, Inc. | 408.85M |
| Iovance Biotherapeutics, Inc. | 6.616B |
| Editas Medicine, Inc. | 444.47M |
| Recursion Pharmaceuticals, Inc. | 2.329B |
Market Cap Related Metrics
| PS Ratio | 24.86 |
| PEG Ratio | -0.2699 |
| Price to Book Value | 6.684 |
| Price | 24.42 |
| Earnings Yield | -15.99% |
| PEGY Ratio | -0.2699 |